Literature DB >> 9668169

The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding.

C L Lorson1, E J Androphy.   

Abstract

Spinal muscular atrophy (SMA) is a motor neuron disorder resulting from anterior horn cell death. Survival motor neuron ( SMN ) is the SMA-determining gene and is deleted or gene converted in >95% of SMA patients. The SMN protein has a role in spliceosomal snRNP biogenesis and has therefore been implicated indirectly in general cellular RNA processing due to its unique sub-nuclear localization within structures termed 'gems', which co-localize with spliceosomal factors within coiled bodies. In this report, direct SMN RNA-binding activity, in addition to ssDNA and dsDNA binding is demonstrated. The region of SMN encoded by exon 2 is necessary and sufficient to mediate its nucleic acid-binding activities. This domain is homologous to several nucleic acid-binding factors, including several high mobility group (HMG) proteins. Additionally, previously reported SMN missense mutations isolated from SMA patients demonstrated reduced RNA-binding activity, suggesting that nucleic acid binding is functionally significant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668169     DOI: 10.1093/hmg/7.8.1269

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  39 in total

1.  Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein.

Authors:  A Broccolini; W K Engel; R B Alvarez; V Askanas
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Neural stem cells: mechanisms and modeling.

Authors:  Jun Yao; Yangling Mu; Fred H Gage
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 3.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

4.  Identification of processing elements and interactors implicate SMN, coilin and the pseudogene-encoded coilp1 in telomerase and box C/D scaRNP biogenesis.

Authors:  Aaron R Poole; Isioma I Enwerem; Ian A Vicino; Jackson B Coole; Stanley V Smith; Michael D Hebert
Journal:  RNA Biol       Date:  2016-07-15       Impact factor: 4.652

Review 5.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

6.  Conditional deletion of SMN in cell culture identifies functional SMN alleles.

Authors:  Anton J Blatnik; Vicki L McGovern; Thanh T Le; Chitra C Iyer; Brian K Kaspar; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-10-19       Impact factor: 6.150

Review 7.  A survey of transcripts generated by spinal muscular atrophy genes.

Authors:  Natalia N Singh; Eric W Ottesen; Ravindra N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-05-06       Impact factor: 4.490

8.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

9.  Fibroblast growth factor-2 regulates the stability of nuclear bodies.

Authors:  Alexander-Francisco Bruns; Jeroen van Bergeijk; Christina Lorbeer; Anna Nölle; Julia Jungnickel; Claudia Grothe; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

10.  Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.

Authors:  D W Parsons; P E McAndrew; S T Iannaccone; J R Mendell; A H Burghes; T W Prior
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.